معرفی
Inés Colmegna, MD is an Associate Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC). She is affiliated with the Infectious Diseases and Immunity in Global Health Program within the Centre for Translational Biology and the Department of Medicine's Division of Rheumatology at the MUHC.
- Academic Appointment: Associate Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University
- Research Affiliation: Scientist, RI-MUHC
- Program Membership: Infectious Diseases and Immunity in Global Health Program, Centre for Translational Biology
- Clinical Division: Department of Medicine, Division of Rheumatology, MUHC
Dr. Colmegna's research focuses on the mechanisms of rheumatoid arthritis development and progression, specifically examining how aging affects immune and stem/progenitor cell function. Her work explores the relationship between aging, immune tolerance, and autoimmune disease risk. A significant portion of her research investigates vaccine responses in rheumatology patients, aiming to enhance protective immunity against vaccine-preventable diseases in this vulnerable population. Her laboratory studies involve human immune cells and stem/progenitor cell systems to understand fundamental immunological processes in aging and autoimmunity.
Her publication record shows consistent output in rheumatology, immunology, and vaccine research since 2005, with increased productivity in recent years (particularly 2019-2024). Key research themes include stem cell biology in aging and disease, vaccine immunology for rheumatology patients, mechanisms of autoimmune disorders, and cellular responses to therapeutic interventions. Her work frequently appears in high-impact rheumatology and immunology journals including The Lancet Rheumatology, Stem Cell Research & Therapy, and Circulation Research.
Dr. Colmegna maintains active collaborations with researchers across multiple institutions, as evidenced by her co-authorship on clinical trials and translational research projects. Her work bridges basic science investigations of cellular mechanisms with clinical applications for improving patient outcomes in rheumatic diseases.
